161 related articles for article (PubMed ID: 6130068)
1. Pharmacology and neurochemistry of buspirone.
Riblet LA; Taylor DP; Eison MS; Stanton HC
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):11-8. PubMed ID: 6130068
[TBL] [Abstract][Full Text] [Related]
2. Buspirone: chemical profile of a new class of anxioselective agents.
Temple DL; Yevich JP; New JS
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):4-10. PubMed ID: 6185470
[TBL] [Abstract][Full Text] [Related]
3. Buspirone: chemistry, pharmacology, and behavior.
Skolnick P; Paul SM
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):40-4. PubMed ID: 6130072
[TBL] [Abstract][Full Text] [Related]
4. Notes on buspirone's mechanisms of action.
Garattini S; Caccia S; Mennini T
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):19-24. PubMed ID: 6130069
[TBL] [Abstract][Full Text] [Related]
5. Buspirone, a novel nonbenzodiazepine anxiolytic.
Kastenholz KV; Crismon ML
Clin Pharm; 1984; 3(6):600-7. PubMed ID: 6150781
[TBL] [Abstract][Full Text] [Related]
6. Effects of buspirone on operant behavior of laboratory rats and cynomolgus monkeys.
Geller I; Hartmann RJ
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):25-33. PubMed ID: 6130070
[TBL] [Abstract][Full Text] [Related]
7. Neuropharmacological profile of buspirone: a non-benzodiazepine anxiolytic with specific mid-brain modulating properties.
Leonard BE
Br J Clin Pract Suppl; 1985 May; 38():74-82. PubMed ID: 2862907
[No Abstract] [Full Text] [Related]
8. Neuropharmacology of buspirone.
Riblet LA; Eison AS; Eison MS; Taylor DP; Temple DL; VanderMaelen CP
Psychopathology; 1984; 17 Suppl 3():69-78. PubMed ID: 6150510
[TBL] [Abstract][Full Text] [Related]
9. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines.
Cryan JF; Kelly PH; Chaperon F; Gentsch C; Mombereau C; Lingenhoehl K; Froestl W; Bettler B; Kaupmann K; Spooren WP
J Pharmacol Exp Ther; 2004 Sep; 310(3):952-63. PubMed ID: 15113848
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of lorazepam.
Gluckman MI; Stein L
J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):3-10. PubMed ID: 30764
[TBL] [Abstract][Full Text] [Related]
11. Dopamine and antianxiety activity.
Taylor DP; Riblet LA; Stanton HC; Eison AS; Eison MS; Temple DL
Pharmacol Biochem Behav; 1982; 17 Suppl 1():25-35. PubMed ID: 6135225
[TBL] [Abstract][Full Text] [Related]
12. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M
J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of 2-o-chlororbenzoyl-4-chloro-N-methyl-N alpha-glycylglycinanilide hydrate (45-0088-S), a compound with benzodiazepine-like properties.
Hirose K; Matsushita A; Eigyo M; Jyoyama H; Fujita A; Tsukinoki Y; Shiomi T; Matsubara K
Arzneimittelforschung; 1981; 31(1):63-9. PubMed ID: 6111327
[TBL] [Abstract][Full Text] [Related]
14. Buspirone: an anxioselective alternative for the management of anxiety disorders.
Riblet LA; Eison AS; Eison MS; Newton RE; Taylor DP; Temple DL
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):663-8. PubMed ID: 6364236
[TBL] [Abstract][Full Text] [Related]
15. Neuro-pharmacological studies on SB 5833, a new psychotherapeutic agent of the benzodiazepine class.
Ferrini R; Miragoli G; Taccardi B
Arzneimittelforschung; 1974 Dec; 24(12):2029-32. PubMed ID: 4156177
[No Abstract] [Full Text] [Related]
16. 5-HT1A receptor agonists buspirone and gepirone attenuate apomorphine-induced aggressive behaviour in adult male Wistar rats.
Pruus K; Skrebuhhova-Malmros T; Rudissaar R; Matto V; Allikmets L
J Physiol Pharmacol; 2000 Dec; 51(4 Pt 2):833-46. PubMed ID: 11220492
[TBL] [Abstract][Full Text] [Related]
17. [A new approach to innovating selective anxiolytics: pharmacological profile of a novel 5-HT1A agonist (tandospirone)].
Sasa M
Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Apr; 17(2):53-9. PubMed ID: 9201724
[TBL] [Abstract][Full Text] [Related]
18. Tolerance to a new class of non-benzodiazepine anxiolytics.
Chodera A; Nowakowska E; Bartczak G
Pol J Pharmacol; 1994; 46(5):479-81. PubMed ID: 7894538
[TBL] [Abstract][Full Text] [Related]
19. Toxicological and pharmacological investigations of pinazepam (7-chloro-1-propargyl-5-phenyl-3H-1,4-benzodiazepin-2-one): a new psychotherapeutic agent.
Scrollini F; Caliari S; Romano A; Torchio P
Arzneimittelforschung; 1975 Jun; 25(6):934-40. PubMed ID: 240369
[TBL] [Abstract][Full Text] [Related]
20. Effect of buspirone on prolactin and growth hormone secretion in laboratory rodents and man.
Meltzer HY; Fleming R
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):76-9. PubMed ID: 6130077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
